- Peptide (C)RQGGASQSDKTPEE, corresponding to amino acid residues 468-481 of human Glucose transporter 1 (Accession P11166). Intracellular, C-terminus.
- Western blot analysis of rat brain membranes (lanes 1 and 3) and mouse brain membranes (lanes 2 and 4):1, 2. Anti-GLUT1 Antibody (#AGT-021), (1:500).
3, 4. Anti-GLUT1 Antibody, preincubated with GLUT1 Blocking Peptide (#BLP-GT021).
- Expression of Glucose Transporter 1 in mouse striatum and wall of lateral ventricleImmunohistochemical staining of perfusion-fixed frozen mouse brain sections using Anti-GLUT1 Antibody (#AGT-021), (1:400), followed by donkey-anti-rabbit-Cy3 secondary antibody (red). GLUT1 staining appears in blood vessels (right-pointing arrows) in the striatum (ST) and in the wall of the lateral ventricle (LV, left-pointing arrow). Cell nuclei were stained with DAPI (blue).
Glucose transporter 1 (GLUT1) belongs to the major facilitator superfamily (MFS), one of the largest and most ubiquitous secondary transporter superfamilies. GLUT1, encoded by SLC2A1, mediates the basal-level cellular uptake of glucose into many tissues. GLUT1 contains 12 membrane-spanning domains with both the amino and carboxyl termini oriented intracellularly. In addition, a single extracellular N-linked glycosylation site is present1.
GLUT1 is widely expressed, but it is most abundant in fibroblasts, erythrocytes, and endothelial cells with low levels of expression in muscle, liver, and adipose tissue2.
Inactivating mutations of GLUT1, resulting in compromised transport activities for glucose, are associated with diseases as a result of lack of energy supply to the brain3. GLUT1 deficiency syndrome (also known as De Vivo syndrome) is characterized by a spectrum of symptoms including early-onset seizures, microcephaly and retarded development4. In addition, elevated expression levels of GLUT1 have been observed in several cancer types, identifying GLUT1 as an important prognostic indicator for tumorigenesis5.
Species reactivity key:
Anti-GLUT1 Antibody (#AGT-021) is a highly specific antibody directed against an epitope of the human Glucose Transporter 1 protein. The antibody can be used in western blot and immunohistochemistry applications. It has been designed to recognize GLUT1 from human, rat, and mouse samples.
- Anti-GLUT1 (extracellular) Antibody (#AGT-041). This antibody recognizes a different epitope and thus can also be used as a control for detecting GLUT1.
- Anti-GLP1R (extracellular)-FITC Antibody (#AGR-021-F)
- Anti-GLUT2 (SLC2A2) Antibody (#AGT-022)
- Anti-GLUT2 (SLC2A2)-ATTO Fluor-488 Antibody (#AGT-022-AG)
- Anti-GLUT3 (extracellular) Antibody (#AGT-023)
- Anti-GLUT3 (extracellular)-FITC Antibody (#AGT-023-F)
- Anti-GLUT4 Antibody (#AGT-024)
- Anti-GLUT4-ATTO Fluor-594 Antibody (#AGT-024-AR)
- Anti-GLUT5 (SLC2A5) Antibody (#AGT-025)
- Anti-Human GLUT3 (extracellular) Antibody (#AGT-043)
- Anti-MCT4 (SLC16A3) Antibody (#AMT-014)
- Anti-SGLT1 (extracellular) Antibody (#AGT-031)
- Anti-SVCT2/SLC23A2 (extracellular) Antibody (#AST-022)